Skip to main content
Contact +1 (919) 234-1277

📢 ProteoGenix Loyalty Program is live — Earn points on every online order. Discover the program

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Pembrolizumab Biosimilar – Anti-PD1 mAb – Research Grade

  • PX-TA1007
Isotype:
IgG4

$143.00

+ 143 loyalty points
Size
Clear
  • In Stock
  • Wide range of unique reagents
  • Fast worldwide delivery
SDS-PAGE for Pembrolizumab Biosimilar - Anti-PD1 mAb
Pembrolizumab Biosimilar - Anti-PD1 mAb binds to CD279 Recombinant Protein in indirect ELISA Assay

Pembrolizumab Biosimilar - Anti-PD1 mAb - Research Grade

Product name Pembrolizumab Biosimilar - Anti-PD1 mAb - Research Grade
Source DrugBank DB09037
Species Human
Molecular weight 149kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Pembrolizumab,Pembrolizumab,PD1,anti-PD1
Reference PX-TA1007
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4
Clonality Monoclonal Antibody
Product name Pembrolizumab Biosimilar - Anti-PD1 mAb - Research Grade
Source DrugBank DB09037
Species Human
Molecular weight 149kDa
Purity >85%
Buffer PBS pH7.5
Delivery condition Blue ice (+4°C)
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition 4°C for short term; -20°C for long term
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Pembrolizumab,Pembrolizumab,PD1,anti-PD1
Reference PX-TA1007
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype IgG4
Clonality Monoclonal Antibody

General information about Pembrolizumab

Pembrolizumab is a humanized antibody used in cancer immunotherapy. This includes to treat melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, and stomach cancer. It is given by slow injection into a vein. It is an IgG4 isotype antibody that blocks a protective mechanism of cancer cells and thereby, allows the immune system to destroy them. It targets the programmed cell death protein 1 (PD-1) receptor of lymphocytes. It works by targeting the cellular pathway of proteins found on the body’s immune cells and some cancer cells, known as PD-1/PD-L1. This product is for research use only.

SDS-PAGE for Pembrolizumab Biosimilar - Anti-PD1 mAb

SDS-PAGE for Pembrolizumab Biosimilar - Anti-PD1 mAb

Pembrolizumab Biosimilar - Anti-PD1 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Pembrolizumab Biosimilar - Anti-PD1 mAb binds to CD279 Recombinant Protein in indirect ELISA Assay

Pembrolizumab Biosimilar - Anti-PD1 mAb binds to CD279 Recombinant Protein in indirect ELISA Assay

Immobilized CD279 Recombinant Protein (cat. No.PX-P4117) at 0.5µg/mL (100µL/well) can bind to Pembrolizumab Biosimilar - Anti-PD1 mAb (cat. No.PX-TA1007) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

There are no reviews yet.

Be the first to review “Pembrolizumab Biosimilar – Anti-PD1 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Recently viewed products

Loading recently viewed products…

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products